Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.

JS, Wolinsky; PA, Narayana; P, O'Connor; PK, Coyle; C, Ford; K, Johnson; A, Miller; L, Pardo; S, Kadosh; D, Ladkani

doi:10.1002/ana.21079

Public

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.

Shared by NobleBlocks on Jan 1, 2007 • 12:00 AM UTC

Authors:

Wolinsky JS

Narayana PA

O'Connor P

Abstract

Objective To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis.Methods A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3-year, double-blind trial. The primary end poi...

Discussions